Literature DB >> 7773503

Immunohistochemical localization of cytochrome P450 2E1 in human pulmonary carcinoma and normal bronchial tissue.

K T Kivistö1, A Linder, G Friedel, P Beaune, C Belloc, H K Kroemer, P Fritz.   

Abstract

Cytochrome P450 2E1 (CYP2E1) is a major xenobiotic-metabolizing enzyme but data concerning its extrahepatic expression are few. CYP2E1 can metabolically activate many procarcinogens and therefore its presence in the lung might play a role in bioactivation of procarcinogens, so we studied the expression and localization of CYP2E1 in primary pulmonary carcinomas and surrounding normal bronchial tissue from 28 patients. Seromucous glands showed expression of CYP2E1 in 19 and bronchial epithelium in 18 of the 28 samples of normal bronchial tissue. Thirteen of the corresponding cases of primary pulmonary carcinoma showed staining for CYP2E1. In 11 of these 13 cases, CYP2E1 was also present in normal bronchial tissue. There was no statistically significant difference in the expression of CYP2E1 between adenocarcinomas and squamous cell carcinomas. No association was observed between the expression of CYP2E1 in tumour tissue and normal bronchial tissue. However, there was a significant correlation between the expression of CYP2E1 in seromucous glands and bronchial epithelium (r = 0.61, P < 0.01) of normal tissue. We conclude that CYP2E1 can be present in both normal and neoplastic bronchial tissue.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7773503     DOI: 10.1007/bf00191361

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  17 in total

Review 1.  Diverse role of pulmonary cytochrome P-450 monooxygenase.

Authors:  Y Kikkawa
Journal:  Lab Invest       Date:  1992-11       Impact factor: 5.662

Review 2.  Oxidative and reductive metabolism by cytochrome P450 2E1.

Authors:  D R Koop
Journal:  FASEB J       Date:  1992-01-06       Impact factor: 5.191

3.  In situ localization and distribution of xenobiotic-activating enzymes and aryl hydrocarbon hydroxylase activity in lungs of untreated rats.

Authors:  J M Voigt; T T Kawabata; J P Burke; M V Martin; F P Guengerich; J Baron
Journal:  Mol Pharmacol       Date:  1990-02       Impact factor: 4.436

Review 4.  [Immunohistochemistry: theoretical potentials and practical application].

Authors:  P Fritz; J Müller; G Wegner; U Braun; A Grau; H V Tuczek; E Moessner; R Schenk
Journal:  Zentralbl Allg Pathol       Date:  1985

Review 5.  The pulmonary uptake, accumulation, and metabolism of xenobiotics.

Authors:  J R Bend; C J Serabjit-Singh; R M Philpot
Journal:  Annu Rev Pharmacol Toxicol       Date:  1985       Impact factor: 13.820

6.  Differential expression of drug metabolizing enzymes in primary and secondary liver neoplasm: immunohistochemical characterization of cytochrome P4503A and glutathione-S-transferase.

Authors:  P Fritz; E Behrle; P Beaune; M Eichelbaum; H K Kroemer
Journal:  Histochemistry       Date:  1993-06

Review 7.  Extrahepatic metabolism of drugs in humans.

Authors:  D R Krishna; U Klotz
Journal:  Clin Pharmacokinet       Date:  1994-02       Impact factor: 6.447

8.  Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors.

Authors:  M Czerwinski; T L McLemore; H V Gelboin; F J Gonzalez
Journal:  Cancer Res       Date:  1994-02-15       Impact factor: 12.701

Review 9.  Ethanol-inducible cytochrome P4502E1: genetic polymorphism, regulation, and possible role in the etiology of alcohol-induced liver disease.

Authors:  M Ingelman-Sundberg; I Johansson; H Yin; Y Terelius; E Eliasson; P Clot; E Albano
Journal:  Alcohol       Date:  1993 Nov-Dec       Impact factor: 2.405

10.  Immunohistochemical localization of cytochrome P450 3A in human pulmonary carcinomas and normal bronchial tissue.

Authors:  K T Kivistö; P Fritz; A Linder; G Friedel; P Beaune; H K Kroemer
Journal:  Histochem Cell Biol       Date:  1995-01       Impact factor: 4.304

View more
  2 in total

1.  Expression of cytochrome P 450 3A enzymes in human lung: a combined RT-PCR and immunohistochemical analysis of normal tissue and lung tumours.

Authors:  K T Kivistö; E U Griese; P Fritz; A Linder; J Hakkola; H Raunio; P Beaune; H K Kroemer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-01       Impact factor: 3.000

Review 2.  Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

Authors:  S Rendic; F P Guengerich
Journal:  Curr Drug Metab       Date:  2010-01       Impact factor: 3.731

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.